Historical record - last NADAC effective date: 8/18/2021
Product Information
BUPROPION HCL 75 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1403 per EA under NDC 69097091707. Its NADAC has been published 169 times since Jun 13, 2018.
FDA first approved this application on Sep 18, 2017.
Strength
75 mg/1
Manufacturer
Cipla USA Inc.NDC
69097091707
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/18/2021
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207389FDA Approved
9/18/2017
On Market Since
5/26/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL 75 MG TABLET has been published 169 times since Jun 13, 2018, and over the history we have for it it has declined 50.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1403 per EA |
|---|---|
| All-time high | $0.2856 (Jun 13, 2018) |
| All-time low | $0.1403 (Aug 18, 2021) |
| Median price | $0.1936 |
| Average price | $0.1947 |
| Largest weekly change | +21.8% (Oct 17, 2018) |
| Weeks tracked | 169 |
| Tracking since | Jun 13, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-50.9%
Last surveyed Sep 1, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bupropion Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPROPION HCL 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL 75 MG TABLET, manufactured by Cipla USA Inc., is $0.1403 per EA (NDC 69097091707), effective Sep 1, 2021.
How has the price of BUPROPION HCL 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL 75 MG TABLET has declined 50.9%. It has been tracked across 169 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL 75 MG TABLET?
Since Jun 13, 2018, the NADAC for BUPROPION HCL 75 MG TABLET has ranged from a low of $0.1403 (Aug 18, 2021) to a high of $0.2856 (Jun 13, 2018), with a median of $0.1936 per EA.
Are there cheaper alternatives to BUPROPION HCL 75 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL 75 MG TABLET, is $0.0928 per EA — about 34% below BUPROPION HCL 75 MG TABLET.
Who manufactures BUPROPION HCL 75 MG TABLET?
BUPROPION HCL 75 MG TABLET (NDC 69097091707) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.